{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:31Z","timestamp":1793729431664,"version":"4.6.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02045-0","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:32:44Z","timestamp":1768210364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative analysis of EAU, AUA, and NCCN guidelines for the management of non-muscle invasive bladder cancer"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-9987","authenticated-orcid":false,"given":"Mehmet Erhan","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7078-0135","authenticated-orcid":false,"given":"Aykut","family":"Ayka\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-2304","authenticated-orcid":false,"given":"Co\u015fkun","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-1723","authenticated-orcid":false,"given":"Mustafa","family":"Sungur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"2","key":"2045_CR1","first-page":"187","volume":"30","author":"ML Kwan","year":"2019","unstructured":"Kwan ML, Kushi LH, Danforth KN, et al. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019;30(2):187\u201393.","journal-title":"Cancer Causes Control"},{"key":"2045_CR2","unstructured":"Gontero P, Birtle A, Comp\u00e9rat E, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (T1, T1 and CIS), in EAU Guidelines, Edn. presented at the 40th EAU Annual Congress Madrid 2025. Available from: https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer."},{"issue":"4","key":"2045_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","volume":"211","author":"JM Holzbeierlein","year":"2024","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment. J Urol. 2024;211(4):533\u20138.","journal-title":"J Urol"},{"key":"2045_CR4","unstructured":"NCCN Clinical Practice Guidelines in Oncology, Bladder Cancer (Version 1.2025) 2025 [Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1417."},{"issue":"2","key":"2045_CR5","first-page":"180","volume":"75","author":"R Contieri","year":"2023","unstructured":"Contieri R, Hurle R, Paciotti M, et al. Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG. Minerva Urol Nefrol. 2023;75(2):180\u20137.","journal-title":"Minerva Urol Nefrol"},{"issue":"1","key":"2045_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.euo.2024.08.001","volume":"8","author":"R Contieri","year":"2025","unstructured":"Contieri R, Soloway MS, Gontero P, et al. Deintensification of treatment for low-grade bladder tumors: a collaborative review by the International Bladder Cancer Group (IBCG). Eur Urol Oncol. 2025;8(1):179\u201389.","journal-title":"Eur Urol Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02045-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02045-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02045-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:47:38Z","timestamp":1770644858000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02045-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":6,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2045"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02045-0","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was not required for this study as it did not involve human participants, or identifiable patient information. Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}